CVRx (CVRX) director Hill, received 8,720 shares
Insider transactions reported
Mitch C. Hill, (director at CVRx Inc., CVRX) reported that they received 8,720 shares on Jun 1, 2026. After these transactions the filing shows 8,720 shares held directly.
- Reporting person
- Hill, Mitch C.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Grant or award (A) | Common Stock1 | +8,720 | - | - | 8,720 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Grant or award (A) | Stock Option (right to buy)On 11,182 Common Stock1 | +11,182 | - | - | 11,182 direct |
Holdings before and after
- Common Stock: 0 to 8,720 direct
- Stock Option (right to buy): 0 to 11,182 direct
Footnotes from the filing
- 1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Hill, report in this CVRX Form 4?
Mitch C. Hill, (director at CVRx Inc., CVRX) reported that they received 8,720 shares on Jun 1, 2026. After these transactions the filing shows 8,720 shares held directly.
How many CVRX shares does Hill, hold after this filing?
The filing shows 8,720 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CVRX
Across the 18 sessions after earlier CVRX headlines, the stock closed higher 8 times and lower 10 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CVRX | SPY |
|---|---|---|---|
| May 28, 2026 | CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | -2.6% | +0.6% |
| May 21, 2026 | CVRx to Present at the William Blair 46th Annual Growth Stock Conference | +0.2% | +0.2% |
| May 14, 2026 | CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy | +10.0% | +0.8% |
| May 12, 2026 | CVRx Reports First Quarter 2026 Financial and Operating Results | -23.8% | -0.2% |
| May 5, 2026 | CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population | -3.8% | +0.8% |
| Apr 28, 2026 | CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 | -2.2% | -0.5% |
Earlier insider filings at CVRX
- Jun 3, 2026Director Ballinger Kevin J. was granted 8,720 shares (SEC Form 4)
- Jun 3, 2026Director Shadan Martha was granted 8,720 shares (SEC Form 4)
- Jun 3, 2026Director Dale Michael D was granted 29,005 shares (SEC Form 4)
- Mar 16, 2026Chief Medical Officer Adamson Philip B. was granted 41,000 shares and sold $9,973 worth of shares (1,262 units at $7.90), increasing direct ownership by 182% to 61,578 units (SEC Form 4)
- Mar 4, 2026CHIEF HUMAN RESOURCES OFFICER Morrison Gregory was granted 34,000 shares (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2021
Follow CVRX and get a push notification the moment its next story breaks.